WolverHeme Happy Hour
by Bernard Marini, Anthony Perissinotti, et al.
Is this your podcast?Insights from recent episode analysis
Audience Interest
Podcast Focus
Publishing Consistency
Platform Reach
Insights are generated by CastFox AI using publicly available data, episode content, and proprietary models.
Most discussed topics
Brands & references
Total monthly reach
Estimated from 3 chart positions in 3 markets.
By chart position
- 🇨🇴CO · Medicine#2210K to 30K
- 🇫🇮FI · Medicine#533K to 10K
- 🇮🇸IS · Medicine#183500 to 3K
- Per-Episode Audience
Est. listeners per new episode within ~30 days
6.8K to 22K🎙 ~2x weekly·47 episodes·Last published 2mo ago - Monthly Reach
Unique listeners across all episodes (30 days)
14K to 43K🇨🇴70%🇫🇮23%🇮🇸7% - Active Followers
Loyal subscribers who consistently listen
4.0K to 13K
Market Insights
Platform Distribution
Reach across major podcast platforms, updated hourly
Total Followers
—
Total Plays
—
Total Reviews
—
* Data sourced directly from platform APIs and aggregated hourly across all major podcast directories.
On the show
From 13 epsHosts
Recent guests
Recent episodes
VAR Review with Dr. Bixby: Reversing the Call on MPAL
Jul 1, 2026
1h 06m 57s
Bispecifics ate CAR-T's lunch: a multiple myeloma debate
Jun 11, 2026
56m 28s
Episode 47: Cult-Like Thinking in BMT
Jun 4, 2026
45m 23s
Spring Cleaning the Evidence from ASH 2025 with Common Sense Oncology
Apr 13, 2026
1h 01m 29s
HLH: From Chaos to Clarity... and Back to Chaos!
Mar 20, 2026
1h 04m 40s
Social Links & Contact
Official channels & resources
Official Website
Login
RSS Feed
Login
| Date | Episode | Topics | Guests | Brands | Places | Keywords | Sponsor | Length | |
|---|---|---|---|---|---|---|---|---|---|
| 7/1/26 | acute leukemiasdiagnosis+4 | Dr. Bixby | MPALALAL+1 | — | acute leukemiaMPAL+4 | — | 1h 06m 57s | ||
| 6/11/26 | multiple myelomaCAR-T therapy+4 | Manni Mohyuddin, MD | Nature Reviews CommentaryCARTITUDE-4+6 | — | multiple myelomaCAR-T+5 | — | 56m 28s | ||
| 6/4/26 | cult-like thinkinghematology+3 | Tate FeeneyAaron Goodman | The impact of cult behavior on haematopoietic cell transplant practices: believers and non-believers | — | cult behaviorhematopoietic cell transplant+3 | — | 45m 23s | ||
| 4/13/26 | oncologyclinical trials+4 | Dr. Eddie CliffDr. Roberta Demichelis+1 | Common Sense Oncology | AustraliaMexico+1 | ASH 2025oncology+5 | — | 1h 01m 29s | ||
| 3/20/26 | hemophagocytic lymphohistiocytosishematology+5 | Justin Kaner, MDMadeleine Ochs, PharmD, BCOP+1 | hemophagocytic lymphohistiocytosis (HLH) | — | HLHhemophagocytic lymphohistiocytosis+5 | — | 1h 04m 40s | ||
| 2/10/26 | uncertaintycancer+4 | Jonathan Gluck | Penguin Random HouseAn Exercise in Uncertainty: A Memoir of Illness and Hope | — | uncertaintymultiple myeloma+5 | — | 46m 18s | ||
| 12/17/25 | leukemiaASH abstracts+3 | Dr. Justin Kaner | Weill Cornell MedicinePARADIGM+5 | — | leukemiaASH 2025+3 | — | 1h 23m 23s | ||
| 12/9/25 | PARADIGM studyASH 2025+3 | — | PARADIGMPARADIGM study | — | PARADIGMASH 2025+3 | — | 41m 25s | ||
| 11/25/25 | myelomaASH abstracts+3 | Manni Mohyuddin | MajesTEC-3ASH | — | myelomaMajesTEC-3+6 | — | 1h 09m 31s | ||
| 10/24/25 | community hematologyinnovative research models+3 | — | community hematologyacademic practices+1 | — | community hematologyresearch models+3 | — | 51m 20s | ||
| 10/9/25 | febrile neutropeniapatient management+3 | — | Chill For 5: The Febrile Neutropenia Survival Guide | — | febrile neutropeniaantibiotics+3 | — | 49m 25s | ||
| 9/10/25 | antimicrobial prophylaxishematology patients+5 | — | hematology | — | prophylaxisantimicrobial+7 | — | 49m 40s | ||
| 7/11/25 | cytarabine dosingAML consolidation+3 | — | cytarabineHunault, et al. NEJM. 2025 | — | cytarabineAML+5 | — | 58m 36s |
Showing 13 of 13
Pitch Fit is a Pro feature
See how bookable this show is for guests, which brands already advertise, the per-episode ad value, and the best-fit guest and sponsor profile. The numbers are blurred on the free plan.
How readily this show books outside guests like you.
How proven this show is for host-read sponsorships.
For Guests
ProFor Advertisers
ProUpgrade to Pro to unlock guest cadence, sponsor categories, fit scores, and per-episode ad value for this show.
Chart history for WolverHeme Happy Hour
Peaked at #22 in CO, currently #22 in CO.
| Market | Genre | Peak | Current | Trend |
|---|---|---|---|---|
| CO | — | #22 | #22 | — |
| Finland | — | #53 | #53 | — |
| IS | — | #183 | #183 | — |
Chart Positions
3 placements across 3 markets.
Chart Positions
3 placements across 3 markets.